Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew A Eisen

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Handbook of Clinical Neurology|September 24, 2008
Chapter 1 Historical aspects of motor neuron diseasesAndrew A Eisen
Handbook of Clinical Neurology|September 24, 2008
Chapter 16 Primary lateral sclerosisAndrew A Eisen
Muscle & Nerve|March 1, 2002
Magnetic stimulation of the central and peripheral nervous systemsMarkus Weber, Andrew A Eisen
Handbook of Clinical Neurology|September 24, 2008
PrefaceAndrew A Eisen, Pamela J Shaw
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|June 19, 2004
Efficacy and safety of xaliproden in amyotrophic lateral sclerosis: results of two phase III trialsVincent Meininger, Gilbert Bensimon, Walter R Bradley, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Handbook of Clinical Neurology|September 24, 2008
Chapter 1 Historical aspects of motor neuron diseasesAndrew A Eisen
Handbook of Clinical Neurology|September 24, 2008
Chapter 16 Primary lateral sclerosisAndrew A Eisen
Muscle & Nerve|March 1, 2002
Magnetic stimulation of the central and peripheral nervous systemsMarkus Weber, Andrew A Eisen
Handbook of Clinical Neurology|September 24, 2008
PrefaceAndrew A Eisen, Pamela J Shaw
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|June 19, 2004
Efficacy and safety of xaliproden in amyotrophic lateral sclerosis: results of two phase III trialsVincent Meininger, Gilbert Bensimon, Walter R Bradley, et al.
Pageof 1